Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 09/30/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 7.11M | 7.11M | 21.97M |
| Total Depreciation and Amortization | -- | -- | 88.60K | 88.60K | 94.50K |
| Total Amortization of Deferred Charges | -- | -- | 498.80K | 498.80K | 456.00K |
| Total Other Non-Cash Items | -- | -- | -9.04M | -9.03M | -24.05M |
| Change in Net Operating Assets | -- | -- | 391.50K | 390.30K | 340.60K |
| Cash from Operations | -- | -- | -942.00K | -942.00K | -1.19M |
| Capital Expenditure | -- | -- | -62.30K | -62.30K | -66.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 21.80K | 21.80K | -118.50K |
| Cash from Investing | -- | -- | -40.50K | -40.50K | -185.40K |
| Total Debt Issued | -- | -- | 1.38M | 1.33M | 1.65M |
| Total Debt Repaid | -- | -- | -446.60K | -446.60K | -311.60K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 57.30K | -- |
| Cash from Financing | -- | -- | 937.80K | 937.80K | 1.34M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -44.70K | -44.70K | -40.00K |